Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change $ Change
grade F $3.76 -0.79% -0.03
ACHN closed down 0.79 percent on Friday, March 24, 2017, on 83 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Mar 24 New Downtrend Bearish 0.00%
Mar 24 Lower Bollinger Band Walk Other 0.00%
Mar 23 Stochastic Reached Oversold Other -0.79%
Mar 23 Bollinger Band Squeeze Range Contraction -0.79%
Mar 23 Lower Bollinger Band Walk Other -0.79%
Mar 22 Bollinger Band Squeeze Range Contraction -2.84%
Mar 21 Bollinger Band Squeeze Range Contraction -2.08%
Mar 20 Bollinger Band Squeeze Range Contraction -6.23%
Mar 17 Bollinger Band Squeeze Range Contraction -5.76%
Mar 14 NR7 Range Contraction -5.05%

Older signals for ACHN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company’s drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.06
52 Week Low 3.75
Average Volume 1,336,284
200-Day Moving Average 6.2671
50-Day Moving Average 4.1326
20-Day Moving Average 4.001
10-Day Moving Average 3.939
Average True Range 0.1644
ADX 25.28
+DI 9.29
-DI: 23.45
Chandelier Exit (Long, 3 ATRs) 3.7868
Chandelier Exit (Short, 3 ATRs) 4.2432
Upper Bollinger Band 4.2132
Lower Bollinger Band 3.7888
Percent B (%b) -0.07
Bandwidth 0.106073